DocuSign, Inc. (NASDAQ:DOCU) Shares Bought by Blue Trust Inc.

Blue Trust Inc. boosted its position in shares of DocuSign, Inc. (NASDAQ:DOCUFree Report) by 1,355.9% in the third quarter, according to the company in its most recent filing with the SEC. The firm owned 1,485 shares of the company’s stock after acquiring an additional 1,383 shares during the quarter. Blue Trust Inc.’s holdings in DocuSign were worth $92,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently added to or reduced their stakes in DOCU. Massmutual Trust Co. FSB ADV lifted its position in DocuSign by 5,000.0% during the 2nd quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company’s stock worth $27,000 after acquiring an additional 500 shares during the period. Mather Group LLC. boosted its stake in shares of DocuSign by 4,338.5% in the second quarter. Mather Group LLC. now owns 577 shares of the company’s stock worth $31,000 after buying an additional 564 shares during the last quarter. nVerses Capital LLC purchased a new stake in shares of DocuSign in the second quarter worth about $48,000. Quarry LP purchased a new stake in shares of DocuSign in the second quarter worth about $53,000. Finally, Thurston Springer Miller Herd & Titak Inc. acquired a new position in DocuSign in the 2nd quarter worth about $72,000. Institutional investors and hedge funds own 77.64% of the company’s stock.

Insider Activity at DocuSign

In related news, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $56.56, for a total value of $30,203.04. Following the completion of the transaction, the director now directly owns 7,202 shares in the company, valued at approximately $407,345.12. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. In related news, CEO Allan C. Thygesen sold 7,725 shares of the stock in a transaction that occurred on Thursday, August 1st. The stock was sold at an average price of $54.89, for a total value of $424,025.25. Following the completion of the transaction, the chief executive officer now directly owns 109,918 shares in the company, valued at approximately $6,033,399.02. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Also, Director Teresa Briggs sold 534 shares of the stock in a transaction that occurred on Monday, September 16th. The stock was sold at an average price of $56.56, for a total value of $30,203.04. Following the completion of the transaction, the director now owns 7,202 shares of the company’s stock, valued at $407,345.12. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 427,554 shares of company stock valued at $23,129,150. 1.66% of the stock is currently owned by insiders.

Analysts Set New Price Targets

A number of equities analysts recently weighed in on the company. Bank of America upped their price target on DocuSign from $60.00 to $68.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Robert W. Baird upped their price target on DocuSign from $55.00 to $59.00 and gave the stock a “neutral” rating in a report on Friday, September 6th. Needham & Company LLC reaffirmed a “hold” rating on shares of DocuSign in a report on Friday, September 6th. Citigroup upped their price target on DocuSign from $86.00 to $87.00 and gave the stock a “buy” rating in a report on Friday, September 6th. Finally, Wells Fargo & Company increased their target price on DocuSign from $48.00 to $50.00 and gave the company an “underweight” rating in a report on Friday, September 6th. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $63.40.

View Our Latest Research Report on DOCU

DocuSign Stock Performance

NASDAQ:DOCU opened at $70.15 on Wednesday. DocuSign, Inc. has a one year low of $38.11 and a one year high of $73.80. The stock has a market cap of $14.24 billion, a PE ratio of 14.80, a P/E/G ratio of 7.33 and a beta of 0.92. The stock has a 50 day moving average price of $62.38 and a 200 day moving average price of $57.78.

DocuSign (NASDAQ:DOCUGet Free Report) last posted its quarterly earnings results on Thursday, September 5th. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.80 by $0.17. DocuSign had a return on equity of 16.18% and a net margin of 34.56%. The firm had revenue of $736.03 million during the quarter, compared to analysts’ expectations of $727.20 million. During the same quarter last year, the firm earned $0.09 earnings per share. The business’s revenue for the quarter was up 7.0% on a year-over-year basis. As a group, analysts predict that DocuSign, Inc. will post 1.01 earnings per share for the current fiscal year.

DocuSign Company Profile

(Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Read More

Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCUFree Report).

Institutional Ownership by Quarter for DocuSign (NASDAQ:DOCU)

Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.